The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Official Title: Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Study ID: NCT01400620
Brief Summary: The purpose of this study is to determine whether an oral rinse composed of botanical extracts is effective in the prevention of severe inflammation of the lining of the oral cavity caused by chemotherapy and radiation therapy for head and neck cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
UF Health Cancer Center, Gainesville, Florida, United States
University of Miami-Sylvester CCC Clinical Research Services, Miami, Florida, United States
Mount Sinai Beth Israel - Phillips Ambulatory Care Center, New York, New York, United States
NYU Clinical Cancer Center, New York, New York, United States
Soroka Medical Center, Beer Sheba, , Israel
Rambam Medical Center, Haifa, , Israel
Rabin Medical Center - Beilinson Campus, Petach Tikva, , Israel
Sourasky Medical Center, Tel Aviv, , Israel
Assuta Medical Center, Tel Aviv, , Israel
Sheba Medical Center, Tel Hashomer, , Israel